Mesirow Financial Investment Management Inc. Lowers Stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Mesirow Financial Investment Management Inc. lessened its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 4.7% in the fourth quarter, Holdings Channel.com reports. The fund owned 3,891 shares of the company’s stock after selling 193 shares during the quarter. Mesirow Financial Investment Management Inc.’s holdings in GE HealthCare Technologies were worth $304,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in GEHC. Janney Montgomery Scott LLC purchased a new stake in GE HealthCare Technologies during the third quarter valued at about $4,367,000. QRG Capital Management Inc. lifted its stake in shares of GE HealthCare Technologies by 7.3% during the third quarter. QRG Capital Management Inc. now owns 7,128 shares of the company’s stock worth $669,000 after purchasing an additional 485 shares in the last quarter. Graypoint LLC lifted its stake in shares of GE HealthCare Technologies by 6.3% during the third quarter. Graypoint LLC now owns 2,768 shares of the company’s stock worth $260,000 after purchasing an additional 164 shares in the last quarter. Capital Performance Advisors LLP acquired a new position in shares of GE HealthCare Technologies during the third quarter worth about $26,000. Finally, SpiderRock Advisors LLC lifted its stake in shares of GE HealthCare Technologies by 11.0% during the third quarter. SpiderRock Advisors LLC now owns 12,092 shares of the company’s stock worth $1,135,000 after purchasing an additional 1,198 shares in the last quarter. Hedge funds and other institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Trading Up 1.4 %

NASDAQ:GEHC opened at $86.58 on Monday. The company has a debt-to-equity ratio of 0.88, a quick ratio of 0.83 and a current ratio of 1.04. The stock has a market cap of $39.59 billion, a price-to-earnings ratio of 20.00, a price-to-earnings-growth ratio of 3.19 and a beta of 1.13. GE HealthCare Technologies Inc. has a one year low of $74.51 and a one year high of $94.80. The business’s 50-day simple moving average is $86.77 and its 200 day simple moving average is $86.16.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings data on Thursday, February 13th. The company reported $1.45 earnings per share for the quarter, beating the consensus estimate of $1.26 by $0.19. The firm had revenue of $5.32 billion during the quarter, compared to analyst estimates of $5.33 billion. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. As a group, sell-side analysts predict that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of research analysts have commented on the company. Jefferies Financial Group upgraded GE HealthCare Technologies from a “hold” rating to a “buy” rating and boosted their price objective for the stock from $95.00 to $103.00 in a research note on Wednesday, January 8th. Wells Fargo & Company boosted their price objective on GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an “overweight” rating in a research note on Friday, February 14th. Finally, Citigroup boosted their price objective on GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a “buy” rating in a research note on Thursday, February 13th. One research analyst has rated the stock with a sell rating, three have given a hold rating, eight have given a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $97.67.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.